Prosecution Insights
Last updated: October 27, 2026

Pauline Wanjiku Much Ondachi, USPTO Patent Examiner

Listed by the USPTO as ONDACHI, PAULINE WANJIKU MUCH

Tech Center 1600 • Art Units: 1627 1629

This examiner grants 100% of resolved cases

Analysis

Pauline Wanjiku Much Ondachi serves as an examiner in Tech Center 1600 and Art Unit 1627. The examiner has 1 resolved case. The data indicates an allowance rate of 100.0 percent and a median days to allowance of 1012. These figures describe the frequency of successful outcomes and the timeframe for the grant process for applications assigned to this examiner.

The interview lift is 0.0 percent, which represents the difference in allowance probability when an interview is conducted. Practitioners can use this 0.0 percent lift to evaluate the potential impact of direct communication. The median days to allowance of 1012 provides a benchmark for the expected duration of prosecution from filing to patent issuance.

Companies on the docket include Boehringer Ingelheim International GmbH, The Regents of the University of California, and Regents of the University of Minnesota. Legal representation is provided by firms such as Alleman Hall LLP, Barron & Young PLLC, and FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER. These firms manage applications within a prosecution environment defined by the 100.0 percent allowance rate. The 1 resolved case forms the basis for these metrics.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
16
Total Applications
+0.0%
Interview Lift
1012
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

11.6%
§101 Eligibility
18.6%
§102 Novelty
30.2%
§103 Obviousness
30.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18542910 PHENYLPIPERIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN Final Rejection Boehringer Ingelheim International GmbH
18709695 IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES Non-Final OA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
18676514 CHIRAL AMINE-SQUARAMIDE COMPOUND BASED ON SPIROBIINDANE SKELETON, PREPARATION METHOD AND USE THEREOF Non-Final OA ZHEJIANG UNIVERSITY
18712594 METHODS FOR TREATING TRAUMATIC BRAIN INJURY Non-Final OA The Regents of the University of California
18569149 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR Non-Final OA LG CHEM, LTD.
18562019 ACID DIANHYDRIDE Non-Final OA MITSUBISHI GAS CHEMICAL COMPANY, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Pauline Wanjiku Much Ondachi's allowance rate?

100.0% of resolved applications examined by Pauline Wanjiku Much Ondachi were allowed (1 resolved cases), compared with 35.1% across Art Unit 1627 over the last five years.

Does an interview help with examiner Pauline Wanjiku Much Ondachi?

This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Pauline Wanjiku Much Ondachi take to allow a patent?

Applications allowed by Pauline Wanjiku Much Ondachi took 1,012 days on average from filing to allowance.

Which art unit does examiner Pauline Wanjiku Much Ondachi work in?

Pauline Wanjiku Much Ondachi examines applications in Art Unit 1627 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month